Our CEO, Simone Leyden raises awareness around neuroendocrine cancer, discusses the recent passing of Irrfan Khan and chats about #LetsWalkforNETs with Ticker Newsroom
BioPharmaDispatch 2025: Putting NETs on the National Agenda NeuroEndocrine Cancer Australia was proud to attend the BioPharmaDispatch 2025 Conference in Sydney this month, represented by
The Cancer Network WA, in collaboration with the WA Clinical Oncology Group at Cancer Council WA, held its second annual one-day symposium “Cancer Network Forum
Thank you to Simone Leyden AM, Director Global Patient Advocacy and Government Affairs at Telix Pharmaceuticals Limited ARCS Australia, for organising sponsorship for a group
On Wednesday 21 May, NeuroEndocrine Cancer Australia (NECA) hosted our annual Strategy Day in Sydney. It’s the one day each year when our entire team
